Quanterix Corporation Announces Executive Terminations at Akoya Biosciences in Cost-Saving Reorganization Plan
I'm PortAI, I can summarize articles.
Quanterix Corporation has announced the termination of certain executives at its subsidiary, Akoya Biosciences, as part of a cost-saving reorganization plan. This strategy aims to achieve annual cash savings of approximately $2.8 million, although it will incur expenses of around $3.3 million in 2025 for severance payments. The company warns that actual results may vary and additional charges could arise during the execution of the plan.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments